Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy

Update: 2009-02-06

Description

This fifth podcast titled Progress and Prognosis: Evaluating Patients’ Responses to Biologic Therapy features a telephone interview with Professor Schett. He discusses differences among the anti-TNF agents in the treatment of rheumatoid arthritis.

Comments

In Channel

Episode 6: Individualizing Therapy: Today’s Options, Tomorrow’s Opportunities

2009-03-0619:02

Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy

2009-02-0616:18

Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity

2008-12-0514:21

Episode 3: Anti-TNF Treatment: Focus on early Rheumatoid Arthritis. Featuring an interview with Professor Paul Emery

2008-10-0314:21

Episode 2: Establishing the Evidence: Clinical Trials with TNF Inhibitors

2008-08-2714:53

Episode 1: TNF-Alpha: Concept to Proof of Concept

2008-05-3014:53

00:00

Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy

Rheumatology News International

#box-pro-ellipsis-176135305308967{-webkit-line-clamp:2;}Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy

Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy

Rheumatology News International

Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy